Incyte Corporation
INCY
$105.98
$0.780.74%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.09% | 18.87% | 17.13% | 14.76% | 12.94% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.09% | 18.87% | 17.13% | 14.76% | 12.94% |
| Cost of Revenue | -24.37% | -15.45% | 56.15% | 54.07% | 40.42% |
| Gross Profit | 101.94% | 80.92% | -16.65% | -20.90% | -18.55% |
| SG&A Expenses | 10.33% | 12.59% | 8.82% | 5.18% | 4.30% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.39% | -5.40% | 36.56% | 35.55% | 32.35% |
| Operating Income | 6,132.53% | 1,434.32% | -66.16% | -82.23% | -96.29% |
| Income Before Tax | 479.94% | 259.53% | -69.11% | -62.04% | -57.47% |
| Income Tax Expenses | 65.57% | 54.26% | 7.44% | 20.03% | 10.27% |
| Earnings from Continuing Operations | 3,559.21% | 795.08% | -97.15% | -94.54% | -92.36% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3,559.21% | 795.08% | -97.15% | -94.54% | -92.36% |
| EBIT | 6,132.53% | 1,434.32% | -66.16% | -82.23% | -96.29% |
| EBITDA | 1,110.62% | 601.65% | -58.24% | -71.69% | -82.13% |
| EPS Basic | 3,563.21% | 1,088.25% | -88.79% | -88.32% | -91.22% |
| Normalized Basic EPS | 673.77% | 432.15% | -46.89% | -60.56% | -70.38% |
| EPS Diluted | 4,144.74% | 1,119.66% | -90.36% | -89.87% | -92.52% |
| Normalized Diluted EPS | 683.09% | 434.36% | -48.42% | -61.82% | -71.17% |
| Average Basic Shares Outstanding | -9.65% | -13.19% | -10.98% | -7.39% | -3.74% |
| Average Diluted Shares Outstanding | -8.25% | -11.97% | -10.55% | -7.18% | -3.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |